Combination of anti-HER3 antibody MM-121/SAR256212 and cetuximab inhibits tumor growth in preclinical models of head and neck squamous cell carcinoma

Ning Jiang; Dongsheng Wang; Zhongliang Hu; Hyung Ju C. Shin; Guoqing Qian; Mohammad Aminur Rahman; Hongzheng Zhang; Arm R. Amin; Sreenivas Nannapaneni; Xiaojing Wang; Zhengjia Chen; Gabriela Garcia; Gavin MacBeath; Dong M. Shin; Fadlo R. Khuri; Jun Ma; Zhuo G. Chen; Nabil F. Saba

Combination of anti-HER3 antibody MM-121/SAR256212 and cetuximab inhibits tumor growth in preclinical models of head and neck squamous cell carcinoma

Ning Jiang
, Dongsheng Wang
, Zhongliang Hu
, Hyung Ju C. Shin
, Guoqing Qian
, Mohammad Aminur Rahman
, Hongzheng Zhang
, Arm R. Amin
, Sreenivas Nannapaneni
, Xiaojing Wang
, Zhengjia Chen
, Gabriela Garcia
, Gavin MacBeath
, Dong M. Shin
, Fadlo R. Khuri
, Jun Ma
, Zhuo G. Chen
, Nabil F. Saba

School of Pharmacy

Research output: Contribution to journal › Article › peer-review

Original language	American English
Journal	Pharmaceutical Science and Research
State	Published - Jul 1 2014

Keywords

EGFR
cetuximab
head and neck
cancer
HNSCC

Disciplines

Medicinal and Pharmaceutical Chemistry
Medicine and Health Sciences
Pharmacy and Pharmaceutical Sciences

Access to Document

https://mct.aacrjournals.org/content/13/7/1826.short

Cite this

Jiang, N., Wang, D., Hu, Z., Shin, H. J. C., Qian, G., Rahman, M. A., Zhang, H., Amin, A. R., Nannapaneni, S., Wang, X., Chen, Z., Garcia, G., MacBeath, G., Shin, D. M., Khuri, F. R., Ma, J., Chen, Z. G., & Saba, N. F. (2014). Combination of anti-HER3 antibody MM-121/SAR256212 and cetuximab inhibits tumor growth in preclinical models of head and neck squamous cell carcinoma. Pharmaceutical Science and Research. https://mct.aacrjournals.org/content/13/7/1826.short

Jiang, N, Wang, D, Hu, Z, Shin, HJC, Qian, G, Rahman, MA, Zhang, H, Amin, AR, Nannapaneni, S, Wang, X, Chen, Z, Garcia, G, MacBeath, G, Shin, DM, Khuri, FR, Ma, J, Chen, ZG & Saba, NF 2014, 'Combination of anti-HER3 antibody MM-121/SAR256212 and cetuximab inhibits tumor growth in preclinical models of head and neck squamous cell carcinoma', Pharmaceutical Science and Research. <https://mct.aacrjournals.org/content/13/7/1826.short>

@article{95233f00526145e0b5bb7262de449273,

title = "Combination of anti-HER3 antibody MM-121/SAR256212 and cetuximab inhibits tumor growth in preclinical models of head and neck squamous cell carcinoma",

keywords = "EGFR, cetuximab, head and neck, cancer, HNSCC",

author = "Ning Jiang and Dongsheng Wang and Zhongliang Hu and Shin, \{Hyung Ju C.\} and Guoqing Qian and Rahman, \{Mohammad Aminur\} and Hongzheng Zhang and Amin, \{Arm R.\} and Sreenivas Nannapaneni and Xiaojing Wang and Zhengjia Chen and Gabriela Garcia and Gavin MacBeath and Shin, \{Dong M.\} and Khuri, \{Fadlo R.\} and Jun Ma and Chen, \{Zhuo G.\} and Saba, \{Nabil F.\}",

note = "Jiang N, Wang D, Hu Z, Shin HJ, Qian G, Rahman MA, Zhang H, Amin AR, Nannapaneni S, Wang X, Chen Z. Combination of anti-HER3 antibody MM-121/SAR256212 and cetuximab inhibits tumor growth in preclinical models of head and neck squamous cell carcinoma. Molecular Cancer Therapeutics. 2014;13(7):1826-36. doi: 10.1158/1535-7163.MCT-13-1093.",

year = "2014",

month = jul,

day = "1",

language = "American English",

journal = "Pharmaceutical Science and Research",

}

TY - JOUR

T1 - Combination of anti-HER3 antibody MM-121/SAR256212 and cetuximab inhibits tumor growth in preclinical models of head and neck squamous cell carcinoma

AU - Jiang, Ning

AU - Wang, Dongsheng

AU - Hu, Zhongliang

AU - Shin, Hyung Ju C.

AU - Qian, Guoqing

AU - Rahman, Mohammad Aminur

AU - Zhang, Hongzheng

AU - Amin, Arm R.

AU - Nannapaneni, Sreenivas

AU - Wang, Xiaojing

AU - Chen, Zhengjia

AU - Garcia, Gabriela

AU - MacBeath, Gavin

AU - Shin, Dong M.

AU - Khuri, Fadlo R.

AU - Ma, Jun

AU - Chen, Zhuo G.

AU - Saba, Nabil F.

N1 - Jiang N, Wang D, Hu Z, Shin HJ, Qian G, Rahman MA, Zhang H, Amin AR, Nannapaneni S, Wang X, Chen Z. Combination of anti-HER3 antibody MM-121/SAR256212 and cetuximab inhibits tumor growth in preclinical models of head and neck squamous cell carcinoma. Molecular Cancer Therapeutics. 2014;13(7):1826-36. doi: 10.1158/1535-7163.MCT-13-1093.

PY - 2014/7/1

Y1 - 2014/7/1

KW - EGFR

KW - cetuximab

KW - head and neck

KW - cancer

KW - HNSCC

UR - https://mds.marshall.edu/sp_psr/136

UR - https://mct.aacrjournals.org/content/13/7/1826.short

M3 - Article

JO - Pharmaceutical Science and Research

JF - Pharmaceutical Science and Research

ER -

Combination of anti-HER3 antibody MM-121/SAR256212 and cetuximab inhibits tumor growth in preclinical models of head and neck squamous cell carcinoma

Keywords

Disciplines

Access to Document

Other files and links

Cite this